BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9042205)

  • 1. Multidrug resistance of testis cancers: the study of clinical relevance of P-glycoprotein expression.
    Eid H; Bodrogi I; Csókay B; Oláh E; Bak M
    Anticancer Res; 1996; 16(6B):3447-52. PubMed ID: 9042205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of MDR1-expression in testicular germ cell cancer.
    Schrader AJ; Seger M; Konrad L; Olbert P; Hegele A; Hofmann R; Heidenreich A
    Exp Oncol; 2007 Sep; 29(3):212-6. PubMed ID: 18004247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor-beta expression in human testicular germ cell tumors.
    Pais V; Leav I; Lau KM; Jiang Z; Ho SM
    Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multidrug resistance of testicular cancers. (Detection of P-glycoprotein and MDR1 gene expression and their clinical connection)].
    Bak M; Hanna E; Csókay B; Bodrogi I; Oláh E
    Orv Hetil; 1995 Jan; 136(1):19-25. PubMed ID: 7845662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins.
    Eid H; Géczi L; Mágori A; Bodrogi I; Institoris E; Bak M
    Anticancer Res; 1998; 18(4C):3059-64. PubMed ID: 9713510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase II alpha expression in testicular germ cell tumors.
    Dimov ND; Zynger DL; Luan C; Kozlowski JM; Yang XJ
    Urology; 2007 May; 69(5):955-61. PubMed ID: 17482942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance gene and P-glycoprotein expression in anaplastic carcinoma of the thyroid.
    Yamashita T; Watanabe M; Onodera M; Shimaoka K; Ito K; Fujimoto Y; Itoyama S; Sugawara I
    Cancer Detect Prev; 1994; 18(5):407-13. PubMed ID: 7812988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung resistance protein analysis in testicular cancer].
    Mándoky L; Géczi L; Doleschall Z; Csuka O; Bodrogi I; Bak M
    Magy Onkol; 2002; 46(4):339-45. PubMed ID: 12563357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is p53 expression, detected by immunohistochemistry, an important parameter of response to treatment in testis cancer?
    Eid H; Van der Looij M; Institoris E; Géczi L; Bodrogi I; Oláh E; Bak M
    Anticancer Res; 1997; 17(4A):2663-9. PubMed ID: 9252698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance in pediatric malignancies.
    Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of multidrug resistance-related markers in primary neuroblastoma.
    Lu QJ; Dong F; Zhang JH; Li XH; Ma Y; Jiang WG
    Chin Med J (Engl); 2004 Sep; 117(9):1358-63. PubMed ID: 15377429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
    Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance in chemotherapy for breast cancer.
    Saeki T; Tsuruo T; Sato W; Nishikawsa K
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mdm-2 expression in human testicular germ-cell tumors and its clinical value.
    Eid H; Institoris E; Géczi L; Bodrogi I; Bak M
    Anticancer Res; 1999; 19(4C):3485-90. PubMed ID: 10629640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDR1 gene expression in primary and advanced breast cancer.
    Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
    Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metallothionein expression as a marker of therapeutic sensitivity in the early stages of testicular cancer].
    Eid H; Institoris E; Bodrogi I; Bak M
    Orv Hetil; 1997 Jan; 138(3):135-9. PubMed ID: 9064626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
    Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of p63 in testicular germ cell neoplasia.
    Emanuel PO; Unger PD; Burstein DE
    Ann Diagn Pathol; 2006 Oct; 10(5):269-73. PubMed ID: 16979518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.